Trial Site Detail

 

Drug:
PLX3397 (PLX108-01)
Trial:
Safety Study of PLX108-01 in Patients With Solid Tumors
Conditions: Solid Tumors
Trial Status:
Ongoing, but not recruiting

 

Dana Farber Cancer Institute

450 Brookline Ave     
Boston , MA 02215-5450
USA

 

Principal Investigator:
Eunice Kwak, MD
Contact:
Andrew Wolanski, NP 617-632-6623 andrew_wolanski@dfci.harvard.edu
Activation Status of this Site:
Closed
Notes about this Site:
Dana Farber Cancer Institute Website:
http://www.dana-farber.org/Research/Clinical-Trials.aspx

 

 

Navigating the Map

Use the plus (+) and minus (-) controls to zoom in/out.

Click and drag the map or use the arrows to move (pan) the map.

Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.